2,900
Views
6
CrossRef citations to date
0
Altmetric
Original Article

First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 1163-1168 | Received 18 May 2021, Accepted 07 Jul 2021, Published online: 28 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kristin Kaasen Jørgensen, Marte Lie Høivik, Adity Chopra, Jūratė Šaltytė Benth, Petr Ricanek, Prof Bjørn Moum, Ingrid Jyssum, Nils Bolstad, David John Warren, Prof John T. Vaage, Prof Ludvig A. Munthe, Prof Knut E.A Lundin, Karoline Anisdahl, Silje Watterdal Syversen, Guro Løvik Goll, Fridtjof Lund-Johansen, Asle W. Medhus & Prof Jørgen Jahnsen. (2023) Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type. Scandinavian Journal of Gastroenterology 58:8, pages 874-882.
Read now

Articles from other publishers (5)

Karoline Anisdahl, Sandre Svatun Lirhus, Asle W Medhus, Bjørn Moum, Hans Olav Melberg & Marte Lie Høivik. (2024) Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study. Digestive and Liver Disease.
Crossref
Anish Kumar Reddy Meda, Fremita Chelsea Fredrick, Urvashi Rathod, Priyanshi Shah & Rohit Jain. (2024) Cardiovascular Manifestations in Inflammatory Bowel Disease. Current Cardiology Reviews 20:1.
Crossref
Thea H Wiken, Marte L Høivik, Karoline Anisdahl, Lydia Buer, David J Warren, Nils Bolstad, Milada Hagen, Bjørn A Moum & Asle W Medhus. (2024) Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study. Crohn's & Colitis 360 6:1.
Crossref
Johan Burisch, Mirabella Zhao, Selwyn Odes, Peter De Cruz, Severine Vermeire, Charles N Bernstein, Gilaad G Kaplan, Dana Duricova, Dan Greenberg, Hans O Melberg, Mamoru Watanabe, Hyeong Sik Ahn, Laura Targownik, Valérie E H Pittet, Vito Annese, KT Park, Konstantinos H Katsanos, Marte L Høivik, Zeljko Krznaric, María Chaparro, Edward V LoftusJrJr, Peter L Lakatos, Javier P Gisbert, Willem Bemelman, Bjorn Moum, Richard B Gearry, Michael D Kappelman, Ailsa Hart, Marieke J Pierik, Jane M Andrews, Siew C Ng, Renata D'Inca & Pia Munkholm. (2023) The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission. The Lancet Gastroenterology & Hepatology 8:5, pages 458-492.
Crossref
Vikash Jaiswal, Nitya Batra, Mehak Dagar, Swatika Butey, Helen Huang, Jia Ee Chia, Sidra Naz, Evbayekha O. Endurance, Nishchita Raj, Srushti Patel, Dipansha Maroo, Song Peng Ang, Muhammed Hanif, Dattatreya Mukherjee, Zouina Sarfraz, Abhigan Babu Shrestha & David Song. (2023) Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic review. Medicine 102:6, pages e32775.
Crossref